Set operating profit, EBITDA, ROE and the dividend payout ratio as new management metrics
First written in FY2023. 4 of 9 entries say "Advanced", first in FY2025. Latest entry: FY2026.
24 other companies' latest entry also says "Reframed".
- FY2026ReframedAnnual report
「To increase corporate value through sustainable growth, the company will improve profitability and management efficiency and, by practicing management that takes capital costs and the share price into account, increase Value (corporate value). It will use net sales, operating profit and ROE as indicators. In addition, it will steadily implement initiatives to improve PER and ROE in order to achieve a PBR of at least 1.0x.」
The company reorganized its indicators from the previously stated operating profit, EBITDA, ROE and dividend payout ratio to a focus on net sales, operating profit and ROE, and added the goal of achieving a PBR of at least 1.0x. - FY2026-H1First-half operating profit and other measures increasedAnnual report
「As a result, for the interim accounting period, net sales were ¥5,620 million, up 4.5% year on year; operating profit was ¥347 million, up 19.6%; ordinary profit was ¥332 million, up 19.3%; and interim net profit was ¥221 million, up 19.3%.」
Among the new management indicators, operating profit, ordinary profit and interim net profit for the current interim accounting period increased from the same period of the previous year. - FY2025AdvancedAnnual report
「Operating profit: ¥191.235 million and ¥595.148 million; EBITDA: ¥528.596 million and ¥944.483 million; ROE (return on equity): 6.2% and 9.5%; dividend payout ratio: 51.6% and 32.5%.」
In FY2025, operating profit, EBITDA and ROE each increased, reaching ¥595 million, ¥944 million and 9.5%, respectively. The dividend payout ratio declined from 51.6% to 32.5%. - FY2025-H1First-half operating profit and other measures increasedAnnual report
「As a result, for the interim accounting period, net sales were ¥5,379 million, up 17.7% year on year; operating profit was ¥290 million, up 288.6%; ordinary profit was ¥278 million, up 59.7%; and interim net profit was ¥185 million, up 66.1%.」
Among the new management indicators, operating profit, ordinary profit and interim net profit for the current interim accounting period increased from the same period of the previous year. EBITDA and ROE were not disclosed in this filing. - FY2024Operating profit, EBITDA and ROE down; dividend payout ratio upAnnual report
「Management indicators for the previous fiscal year and the current fiscal year were as follows: … operating profit: ¥427.180 million and ¥191.235 million; EBITDA: ¥689.828 million and ¥528.596 million; ROE (return on equity): 11.3% and 6.2%; dividend payout ratio: 27.9% and 51.6%.」
Among the new management indicators, operating profit, EBITDA and ROE declined in FY2024, while the dividend payout ratio rose to 51.6%. - FY2023First statedAnnual report
「To enhance profitability and improve management efficiency with the aim of increasing corporate value through sustainable growth, the company had previously positioned net sales and gross profit margin as important management indicators. To achieve management that takes capital costs and the share price into account, it has newly adopted operating profit, EBITDA, ROE and the dividend payout ratio as indicators. Going forward, it aims to improve each indicator by implementing the initiatives in its medium-term management plan “Dreambed2025 Change & Challenge Plan.”」
The company expanded its indicators from a focus on net sales and gross profit margin to operating profit, EBITDA, ROE and the dividend payout ratio, and indicated a policy of taking capital costs and the share price into account.